Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines
Edurne Arriola(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Chris Jones(North Carolina State University), Rachael Natrajan(Institute of Cancer Research), Mitch Dowsett(Institute of Cancer Research), Alan Ashworth(University of California, San Francisco), David S.P. Tan(National University of Singapore), Caterina Marchiò(Candiolo Cancer Institute), Narinder Tamber(Institute of Cancer Research), Alan Mackay(Institute of Cancer Research), Suzanne Drury(Gender Studies), Kerry Fenwick(Institute of Cancer Research), Maryou B. Lambros(Institute of Cancer Research), Socorro Marıá Rodríguez-Pinilla(Centro Nacional de Investigaciones Científicas)
Cited by 152
Related Papers
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k